Cargando…
Recent Advances in Liposomal-Based Anti-Inflammatory Therapy
Liposomes can be seen as ideal carriers for anti-inflammatory drugs as their ability to (passively) target sites of inflammation and release their content to inflammatory target cells enables them to increase local efficacy with only limited systemic exposure and adverse effects. Nonetheless, few li...
Autores principales: | van Alem, Carla M. A., Metselaar, Josbert M., van Kooten, Cees, Rotmans, Joris I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309101/ https://www.ncbi.nlm.nih.gov/pubmed/34371695 http://dx.doi.org/10.3390/pharmaceutics13071004 |
Ejemplares similares
-
Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection
por: van Alem, Carla M.A., et al.
Publicado: (2020) -
Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment
por: Alaarg, Amr, et al.
Publicado: (2016) -
Liposomal prednisolone inhibits vascular inflammation and enhances venous outward remodeling in a murine arteriovenous fistula model
por: Wong, ChunYu, et al.
Publicado: (2016) -
Development and characterization of liposomal formulation of bortezomib
por: Deshantri, Anil K., et al.
Publicado: (2019) -
Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis
por: Wong, Chee Wai, et al.
Publicado: (2018)